CGNU PLC
22 May 2001
CGNU sells its main Belgian general insurance subsidiary
CGNU plc announces that it has signed a binding agreement to sell to
Winterthur-Europe Assurances SA (the Credit Suisse Group subsidiary
in Belgium) the entire issued share capital of CGU SA, its main general
insurance business in Belgium, for some £72m. CGU SA had gross written
premiums of £106m in 2000. CGNU is currently conducting a strategic
review into its remaining general insurance activities in Belgium.
The disposal reflects the Group's strategy to exit businesses in
which it has insufficient scale or where growth prospects are limited.
CGNU remains committed to building its long-term savings business in Belgium
through Delta Lloyd Nuts Ohra.
The transaction is subject to regulatory approval and is expected to be
completed in the second half of 2001.
Enquiries:
Analysts
Steve Riley, Investor Relations Director Tel: +44 (0) 20 7662 8115
Media
Alex Child-Villiers, Financial Dynamics Tel: +44 (0) 20 7269 7107
Notes to editors:
* CGNU plc is the UK's largest insurance group and the world's sixth
largest insurer based on gross worldwide premiums.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.